Janus Henderson Group plc 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 12:23 pm Sale | 2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB | JANUS HENDERSON GROUP PLC JHG | 483 0.000% | -11,247,809 (-100.00%) | Filing |
| 2023-02-10 11:46 am Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | JANUS HENDERSON GROUP PLC JHG | 11,248,292 9.000% | 6,193,193 (+122.51%) | Filing |
| 2022-02-11 3:11 pm Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | JANUS HENDERSON GROUP PLC JHG | 5,055,099 5.500% | 5,055,099 (New Position) | Filing |